# CRSP (Crispr Therapeutics AG) - SEC EDGAR Financial Statements

> Crispr Therapeutics AG reported $25.17M in revenue and a net loss of $456.1M for the trailing twelve months ended September 30, 2026 (up 1325.1% year over year), with a -2114.8% operating margin.

- Canonical: https://convexityos.com/fundamentals/CRSP
- Markdown: https://convexityos.com/fundamentals/CRSP.md
- SEC CIK: 0001674416
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:17 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001674416&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $25.17M | +1325.1% YoY |
| Operating Income | TTM | -$532.3M | -2114.8% margin |
| Net Income | TTM | -$456.1M | -1812.1% net margin |
| Diluted EPS | TTM | -$4.71 | Split-adjusted |
| Free Cash Flow | TTM | -$376.7M | -1496.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $2.27B | Total debt: $779.8M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $3.51M | $37.31M | $371.2M | $1.20M | $915.0M | $719K | $289.6M | $3.12M | $41.00M | $5.16M |
| Research & Development | $284.8M | $310.2M | $387.3M | $461.6M | $340.6M | $221.4M | $179.4M | $113.8M | $69.80M | $42.24M |
| Total Operating Expenses | $668.1M | $503.9M | $593.7M | $674.4M | $541.4M | $355.2M | $242.8M | $162.1M | $105.6M | $73.29M |
| **Operating Income** | -$664.6M | -$466.6M | -$222.5M | -$673.2M | $373.5M | -$354.4M | $46.74M | -$158.9M | -$64.65M | -$68.13M |
| **EBITDA** | -$645.1M | -$447.3M | -$202.7M | -$649.0M | $391.5M | -$345.3M | $51.47M | -$155.4M | -$61.62M | -$67.20M |
| Interest Income | -- | $104.3M | $76.40M | $23.30M | -- | -- | -- | -- | -- | -- |
| Income Before Tax | -$578.0M | -$362.7M | -$150.7M | -$650.5M | $379.5M | -$348.1M | $67.31M | -$164.4M | -$66.61M | -$22.72M |
| Income Tax Expense | $3.63M | $3.59M | $2.89M | -$325K | $1.87M | $809K | $448K | $553K | $1.75M | $484K |
| **Net Income** | -$581.6M | -$366.3M | -$153.6M | -$650.2M | $377.7M | -$348.9M | $66.86M | -$165.0M | -$68.36M | -$23.18M |
| Basic EPS | -$6.47 | -$4.34 | -$1.94 | -$8.36 | $4.97 | -$5.29 | $1.23 | -$3.44 | -$1.71 | -$1.89 |
| **Diluted EPS** | -$6.47 | -$4.34 | -$1.94 | -$8.36 | $4.70 | -$5.29 | $1.17 | -$3.44 | -$1.71 | -$1.89 |
| Basic Shares Outstanding | 89.9M | 84.4M | 79.2M | 77.7M | 75.9M | 65.9M | 54.4M | 48.0M | 40.1M | 12.3M |
| Diluted Shares Outstanding | 89.9M | 84.4M | 79.2M | 77.7M | 80.4M | 65.9M | 56.9M | 48.0M | 40.1M | 12.3M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $12.67M | $10.18M | $1.46M | $864K | $889K | $892K | $865K | $35.69M |
| Research & Development | $71.89M | $67.15M | $68.57M | $83.53M | $58.90M | $69.89M | $72.48M | $71.74M |
| Total Operating Expenses | $142.7M | $127.5M | $131.7M | $155.6M | $132.9M | $230.2M | $149.3M | $100.3M |
| **Operating Income** | -$130.0M | -$117.3M | -$130.2M | -$154.8M | -$132.1M | -$229.3M | -$148.4M | -$64.59M |
| **EBITDA** | -$125.8M | -$113.0M | -$125.9M | -$149.1M | -$127.6M | -$224.7M | -$143.7M | -$59.75M |
| Interest Expense | $3.33M | $3.32M | $553K | -- | $0 | $0 | $0 | -- |
| Income Before Tax | -$111.4M | -$90.19M | -$122.1M | -$130.0M | -$105.8M | -$207.3M | -$134.9M | -$36.61M |
| Income Tax Expense | $74K | $960K | $839K | $614K | $619K | $1.29M | $1.11M | $700K |
| **Net Income** | -$111.4M | -$91.15M | -$122.9M | -$130.6M | -$106.4M | -$208.5M | -$136.0M | -$37.31M |
| Basic EPS | -$1.15 | -$0.94 | -$1.28 | -- | -$1.17 | -$2.40 | -$1.58 | -- |
| **Diluted EPS** | -$1.15 | -$0.94 | -$1.28 | -- | -$1.17 | -$2.40 | -$1.58 | -- |
| Basic Shares Outstanding | 96.7M | 96.5M | 96.1M | -- | 91.3M | 87.1M | 85.9M | -- |
| Diluted Shares Outstanding | 96.7M | 96.5M | 96.1M | -- | 91.3M | 87.1M | 85.9M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $347.6M | $298.3M | $389.5M | $211.9M | $923.0M | $1.17B | $943.8M | $456.6M | $239.8M | $315.5M |
| Short-Term Investments | $1.63B | $1.61B | $1.30B | $1.60B | $1.46B | $521.7M | $0 | -- | -- | -- |
| **Cash & Short-Term Investments** | $1.98B | $1.90B | $1.69B | $1.82B | $2.38B | $1.69B | $943.8M | $456.6M | $239.8M | $315.5M |
| Accounts Receivable, Net | $0 | $25.00M | $200.0M | $0 | $305K | $144K | $99K | $88K | $2.63M | $3.16M |
| **Total Current Assets** | $1.99B | $1.94B | $1.91B | $1.85B | $2.42B | $1.72B | $987.5M | $466.4M | $248.4M | $320.2M |
| Property, Plant & Equipment, Net | $115.9M | $134.1M | $151.9M | $163.6M | $137.6M | $42.16M | $31.33M | $18.50M | $18.86M | $21.03M |
| Intangible Assets | -- | $0 | $16K | $71K | $125K | $180K | $235K | $289K | $344K | $399K |
| Long-Term Investments | $0 | $0 | $1.97M | $53.13M | $0 | -- | -- | -- | -- | -- |
| Other Non-Current Assets | $24.37M | $15.83M | $1.98M | $4.64M | $5.29M | $1.29M | $1.10M | $669K | $606K | $198K |
| **Total Non-Current Assets** | $279.6M | $304.9M | $321.5M | $390.0M | $334.4M | $111.3M | $79.20M | $22.62M | $22.96M | $24.77M |
| **Total Assets** | $2.27B | $2.24B | $2.23B | $2.24B | $2.75B | $1.83B | $1.07B | $489.0M | $271.3M | $345.0M |
| Accounts Payable | $11.14M | $14.71M | $38.15M | $27.43M | $14.82M | $9.09M | $5.94M | $5.07M | $1.64M | $4.57M |
| Deferred Revenue (Current) | $15.77M | $3.85M | $4.11M | $0 | $1.01M | $2.34M | $960K | $102K | -- | -- |
| Other Current Liabilities | $13.11M | $10.42M | $5.14M | $20K | $171K | $7.21M | $10.95M | $119K | $137K | $59K |
| **Total Current Liabilities** | $149.1M | $87.78M | $108.8M | $121.1M | $119.9M | $94.26M | $57.11M | $27.75M | $14.51M | $22.00M |
| Long-Term Debt | $0 | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | $0 | $12.32M | $14.01M | $12.32M | $12.32M | $11.78M | $11.78M | $57.78M | $56.93M | $77.65M |
| Other Non-Current Liabilities | $6.14M | $3.44M | $958K | $5.97M | $7.34M | $7.63M | $14.39M | $243K | $314K | $189K |
| **Total Non-Current Liabilities** | $194.3M | $222.2M | $238.0M | $246.5M | $232.5M | $69.47M | $70.22M | $69.08M | $69.00M | $90.12M |
| **Total Liabilities** | $343.4M | $310.0M | $346.8M | $367.6M | $352.4M | $163.7M | $127.3M | $96.82M | $83.51M | $112.1M |
| **Total Debt (incl. Leases)** | $206.7M | $223.7M | $238.6M | $244.0M | $225.0M | $61.43M | $52.54M | -- | -- | -- |
| Common Stock | $3.09M | $2.70M | $2.50M | $2.44M | $2.39M | $2.28M | $1.85M | $1.58M | $1.24M | $1.22M |
| Retained Earnings | -$1.95B | -$1.37B | -$999.7M | -$846.1M | -$195.9M | -$573.6M | -$224.7M | -$291.6M | -$125.4M | -$57.08M |
| Accumulated Other Comp. Income | $4.82M | $1.84M | $1.91M | -$15.65M | -$5.07M | -$83K | $7.0K | -$8.0K | $14K | -$26K |
| **Total Stockholders' Equity** | $1.92B | $1.93B | $1.88B | $1.88B | $2.40B | $1.66B | $939.4M | $392.2M | $187.8M | $232.8M |
| Total Equity | $1.92B | $1.93B | $1.88B | $1.88B | $2.40B | $1.66B | $939.4M | $392.2M | $187.8M | $232.8M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $192.0M | $291.3M | $423.3M | $347.6M | $286.5M | $193.6M | $235.2M | $298.3M |
| Short-Term Investments | $2.08B | $2.07B | $2.02B | $1.63B | $1.63B | $1.53B | $1.62B | $1.61B |
| **Cash & Short-Term Investments** | $2.27B | $2.36B | $2.44B | $1.98B | $1.92B | $1.72B | $1.86B | $1.90B |
| Accounts Receivable, Net | -- | -- | -- | $0 | $0 | $0 | $0 | $25.00M |
| **Total Current Assets** | $2.29B | $2.37B | $2.45B | $1.99B | $1.93B | $1.73B | $1.87B | $1.94B |
| Property, Plant & Equipment, Net | $104.3M | $108.1M | $112.2M | $115.9M | $120.8M | $124.9M | $129.4M | $134.1M |
| Intangible Assets | -- | -- | -- | -- | -- | -- | -- | $0 |
| Long-Term Investments | $4.02M | $0 | $0 | $0 | $28.41M | $0 | $0 | $0 |
| Other Non-Current Assets | $32.78M | $37.71M | $28.98M | $24.37M | $24.31M | $25.47M | $20.78M | $15.83M |
| **Total Non-Current Assets** | $271.3M | $279.0M | $277.5M | $279.6M | $316.2M | $296.0M | $298.5M | $304.9M |
| **Total Assets** | $2.56B | $2.65B | $2.73B | $2.27B | $2.25B | $2.03B | $2.17B | $2.24B |
| Accounts Payable | $20.59M | $11.31M | $13.65M | $11.14M | $11.80M | $9.75M | $13.06M | $14.71M |
| Deferred Revenue (Current) | $2.55M | $15.19M | $15.34M | $15.77M | $1.29M | $2.13M | $3.02M | $3.85M |
| Other Current Liabilities | $17.00M | $16.98M | $13.11M | $13.11M | $0 | $0 | $0 | $10.42M |
| **Total Current Liabilities** | $141.0M | $132.9M | $136.3M | $149.1M | $119.0M | $104.4M | $119.4M | $87.78M |
| Long-Term Debt | $586.9M | $586.2M | $585.5M | $0 | -- | -- | -- | -- |
| Deferred Revenue (Non-Current) | -- | -- | -- | $0 | $12.32M | $12.32M | $12.32M | $12.32M |
| Other Non-Current Liabilities | $6.24M | $6.22M | $5.95M | $6.14M | $5.28M | $4.48M | $3.32M | $3.44M |
| **Total Non-Current Liabilities** | $767.4M | $771.3M | $775.0M | $194.3M | $210.4M | $214.2M | $217.5M | $222.2M |
| **Total Liabilities** | $908.3M | $904.2M | $911.3M | $343.4M | $329.3M | $318.6M | $336.9M | $310.0M |
| **Total Debt (incl. Leases)** | $779.8M | $783.7M | $787.6M | $206.7M | $211.0M | $215.5M | $219.4M | $223.7M |
| Common Stock | $3.15M | $3.13M | $3.12M | $3.09M | $3.01M | $2.79M | $2.72M | $2.70M |
| Retained Earnings | -$2.27B | -$2.16B | -$2.07B | -$1.95B | -$1.82B | -$1.71B | -$1.50B | -$1.37B |
| Accumulated Other Comp. Income | -$14.08M | -$4.63M | -$1.94M | $4.82M | $4.99M | $4.04M | $4.13M | $1.84M |
| **Total Stockholders' Equity** | $1.65B | $1.75B | $1.81B | $1.92B | $1.92B | $1.71B | $1.83B | $1.93B |
| Total Equity | $1.65B | $1.75B | $1.81B | $1.92B | $1.92B | $1.71B | $1.83B | $1.93B |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$581.6M | -$366.3M | -$153.6M | -$650.2M | $377.7M | -$348.9M | $66.86M | -$165.0M | -$68.36M | -$23.20M |
| Depreciation & Amortization | $19.48M | $19.26M | $19.84M | $24.17M | $17.95M | $9.18M | $4.72M | $3.52M | $3.02M | $925K |
| Stock-Based Compensation | $72.50M | $86.57M | $81.03M | $97.95M | $102.4M | $66.02M | $44.06M | $34.98M | $18.87M | $10.84M |
| Change in Receivables | $25.00M | $175.0M | -$200.0M | $305K | -$161K | -$45K | -$11K | $2.54M | $531K | -$2.82M |
| **Operating Cash Flow** | -$345.0M | -$142.8M | -$260.4M | -$495.7M | $539.0M | -$238.4M | $56.68M | -$96.24M | -$70.09M | -$52.86M |
| Capital Expenditure | -$914K | -$1.90M | -$9.47M | -$37.19M | -$81.70M | -$18.36M | -$6.68M | -$2.77M | -$7.81M | -$3.02M |
| **Free Cash Flow** | -$345.9M | -$144.7M | -$269.8M | -$532.9M | $457.3M | -$256.7M | $49.99M | -$99.01M | -$77.91M | -$55.88M |
| Purchases of Investments | -$1.01B | -$1.46B | -$1.07B | -$1.42B | -$1.51B | -$594.0M | -- | -- | -$500K | -- |
| **Investing Cash Flow** | -$31.80M | -$280.5M | $374.6M | -$258.7M | -$1.04B | -$541.2M | $1.32M | -$2.77M | -$8.31M | $31.88M |
| Common Stock Issued | $398.1M | $300.7M | $32.72M | $970K | $213.3M | $982.3M | $415.0M | $307.1M | $0 | $89.06M |
| Share Repurchases | -- | -- | -- | -- | -- | -- | -- | -$57K | -- | -- |
| **Financing Cash Flow** | $426.0M | $332.0M | $62.66M | $38.59M | $250.9M | $1.02B | $431.0M | $315.9M | $2.61M | $183.2M |
| **Net Change in Cash** | $49.30M | -$91.29M | $177.0M | -$715.9M | -$245.5M | $236.7M | $489.0M | $216.9M | -$75.76M | $162.0M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$111.4M | -$91.15M | -$122.9M | -$130.6M | -$106.4M | -$208.5M | -$136.0M | -$37.31M |
| Depreciation & Amortization | $4.24M | $4.28M | $4.32M | $5.66M | $4.43M | $4.65M | $4.74M | $4.84M |
| Stock-Based Compensation | $17.96M | $17.32M | $16.32M | $18.08M | $16.60M | $17.61M | $20.21M | $21.95M |
| Change in Receivables | $0 | $0 | $0 | $0 | $0 | $0 | $25.00M | -$25.00M |
| **Operating Cash Flow** | -$89.68M | -$83.50M | -$108.9M | -$92.55M | -$84.63M | -$113.9M | -$53.95M | -$50.03M |
| Capital Expenditure | -$414K | -$648K | -$504K | -$517K | -$74K | -$117K | -$206K | -$254K |
| **Free Cash Flow** | -$90.10M | -$84.15M | -$109.4M | -$93.07M | -$84.71M | -$114.0M | -$54.15M | -$50.28M |
| Purchases of Investments | -$321.3M | -$206.3M | -$746.1M | -$263.0M | -$334.1M | -$210.4M | -$200.7M | -$264.1M |
| **Investing Cash Flow** | -$14.09M | -$55.66M | -$410.7M | $37.20M | -$119.2M | $69.98M | -$19.75M | $105.8M |
| Common Stock Issued | $0 | $0 | -$722K | $111.5M | $278.1M | -$22K | $8.52M | $14.96M |
| **Financing Cash Flow** | $4.45M | $7.18M | $591.9M | $116.4M | $296.8M | $2.26M | $10.59M | $16.88M |
| **Net Change in Cash** | -$99.31M | -$132.0M | $72.24M | $61.06M | $92.88M | -$41.56M | -$63.07M | $72.59M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -18933.6% | -1250.4% | -60.0% | -56190.4% | 40.8% | -49295.5% | 16.1% | -5087.8% | -157.7% | -1319.3% |
| **Net Profit Margin** | -16569.8% | -981.5% | -41.4% | -54271.7% | 41.3% | -48520.9% | 23.1% | -5281.1% | -166.7% | -448.8% |
| Return on Equity (ROE) | -30.3% | -19.0% | -8.2% | -34.7% | 15.7% | -21.0% | 7.1% | -42.1% | -36.4% | -10.0% |
| Return on Assets (ROA) | -25.7% | -16.3% | -6.9% | -29.0% | 13.7% | -19.1% | 6.3% | -33.7% | -25.2% | -6.7% |
| Current Ratio | 13.32x | 22.07x | 17.54x | 15.30x | 20.17x | 18.21x | 17.29x | 16.81x | 17.12x | 14.56x |
| Quick Ratio | 13.25x | 21.97x | 17.41x | 14.99x | 19.85x | 17.93x | 16.53x | 16.46x | 16.70x | 14.49x |
| Debt to Equity | 0.11x | 0.12x | 0.13x | 0.13x | 0.09x | 0.04x | 0.06x | -- | -- | -- |
| **Revenue Growth (YoY)** | -90.6% | -89.9% | +30885.5% | -99.9% | +127154.9% | -99.8% | +9169.8% | -92.4% | +693.9% | +1990.7% |
| Operating Income Growth (YoY) | -- | -- | -- | -280.2% | -- | -858.3% | -- | -- | -- | -- |
| **Net Income Growth (YoY)** | -- | -- | -- | -272.2% | -- | -621.8% | -- | -- | -- | -- |
| EPS Growth (YoY) | -- | -- | -- | -268.2% | -- | -530.1% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -192.0% | -- | -520.6% | -- | -- | -- | -188.9% |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -216.5% | -- | -613.5% | -- | -- | -- | -195.9% |
| 5Y Revenue / Share Growth | +258.0% | -91.7% | +7094.2% | -98.5% | +2759.6% | -77.8% | -- | -- | -- | -- |
| 10Y Revenue / Share Growth | -20.4% | -- | -- | -- | -- | -- | -- | -- | -- | -- |
| 5Y Net Income / Share Growth | -- | -453.2% | -- | -- | -- | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -2114.8% | -3990.0% | -15754.2% | -18933.6% | -1498.3% | -1451.9% | -1259.2% | -1250.4% |
| **Net Profit Margin** | -1812.1% | -3368.7% | -13856.5% | -16569.8% | -1273.7% | -1229.4% | -1023.6% | -981.5% |
| Return on Equity (ROE) | -27.7% | -25.8% | -31.3% | -30.3% | -25.5% | -27.3% | -21.1% | -19.0% |
| Return on Assets (ROA) | -17.8% | -17.0% | -20.9% | -25.7% | -21.7% | -23.0% | -17.8% | -16.3% |
| Current Ratio | 16.21x | 17.85x | 17.96x | 13.32x | 16.22x | 16.61x | 15.64x | 22.07x |
| Quick Ratio | 16.12x | 17.79x | 17.92x | 13.25x | 16.10x | 16.49x | 15.53x | 21.97x |
| Debt to Equity | 0.47x | 0.45x | 0.43x | 0.11x | 0.11x | 0.13x | 0.12x | 0.12x |
| **Revenue Growth (YoY)** | +1325.1% | +1041.4% | +68.6% | -97.6% | +47.7% | +72.5% | +71.6% | -82.3% |
| Operating Income Growth (YoY) | -- | -- | -- | -- | -- | -- | -- | -192.8% |
| **Net Income Growth (YoY)** | -- | -- | -- | -- | -- | -- | -- | -141.8% |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -149.2% | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -- | -- | -- | -149.7% | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
